CN105055922A - Acupuncture point application composition for treating hypertension and using method thereof - Google Patents
Acupuncture point application composition for treating hypertension and using method thereof Download PDFInfo
- Publication number
- CN105055922A CN105055922A CN201510533053.4A CN201510533053A CN105055922A CN 105055922 A CN105055922 A CN 105055922A CN 201510533053 A CN201510533053 A CN 201510533053A CN 105055922 A CN105055922 A CN 105055922A
- Authority
- CN
- China
- Prior art keywords
- parts
- point
- application prescription
- acupuncture point
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses an acupuncture point application composition for treating hypertension and a using method thereof. The acupuncture point application composition comprises, by weight, the raw material Chinese herbs of 20-40 parts of fructus evodiae, 20-40 parts of magnetite, 20-40 parts of radix achyranthis bidentatae, 20-40 parts of eucommia ulmoides, 20-40 parts of rhizoma gastrodiae, 20-40 parts of dens draconis and 1-5 parts of cinnabar. The acupuncture point application composition is unique in formula, has the simple herbs with concentrated effects and has a remarkable effect. The acupuncture point application composition has the effects of nursing vital essence of the liver and the kidneys, ensuring proper downward flow of blood, repressing wind-yang and mildly regulating blood and qi. A patient only needs to apply the composition to the Yongquan acupuncture point of one foot sole according to the treatment course, the treatment method is simple and convenient to implement, and the acupuncture point application composition is safe, free of risks and remarkable in effect.
Description
Technical field
The present invention relates to one and treat hypertensive point-application prescription and using method thereof.
Background technology
Along with the raising of living standards of the people and the quickening of rhythm of life, hypertensive patient increases increasingly, and China's cerebrovascular occupies the second of urbanite's cause of death, ranks first in rural area.The annual death in the whole nation is more than 1,000,000, and the patient about 5,000,000 ~ 6,000,000 of survival, wherein more than 75% leaves deformity in various degree, causes white elephant to individual, family and society.
Hypertensive symptom varies with each individual.Early stage possibility is asymptomatic or symptom is not obvious, blood pressure only can occur after fatigue, psychentonia, anxious state of mind and raise, and recover normal after rest.Along with the course of disease extends, blood pressure significantly continues to raise, and there will be various symptom gradually.Common clinical symptoms has headache, dizziness, absent minded, hypomnesis, numb limbs and tense tendons, nocturia increase, cardiopalmus, uncomfortable in chest, weak etc.Even there will be severe headache, vomiting, cardiopalmus, the symptom such as dizzy when blood pressure is elevated to a certain degree suddenly, time serious, obnubilation, tic can occur.This just belongs to accelerated hypertension and hypertension critical illness, infringement and the pathological changes of the organs such as the serious heart, brain, kidney can occur in a short time, as apoplexy, heart infarction, renal failure etc.Meanwhile, blood pressure raises or the fuse cord of cardiovascular terminal affair, and the onset risk of the diseases such as coronary heart disease, heart failure, apoplexy and kidney disease can be made to increase.
Therefore, hypertensive control is all the focus of medical domain research all the time.The depressor kind of Hypertension is a lot of both at home and abroad at present, and great majority are all oral medicine, need long-term taking, and different medicines has corresponding side effect.
Hypertension belongs to the category such as " dizzy ", " headache " in the traditional Chinese medical science, and basic pathogenesis is: Liver and kidney deficiency in origin, and wind syndrome caused by deficiency is disturbed, and the fiery all heresies of the expectorant stasis of blood are taken advantage of a weak point in opponent's defence away string, uneasy one's own department or unit.We select tool nourishing the liver and kidney, dive and fall wind syndrome caused by deficiency, easing the affected liver blood stasis dispelling by the Chinese medicine of expectorant, act on specific meridian point, Transdermal absorption, play Heibei provincial opera QI and blood, Yin Yang balancing effect, make inverse vim and vigour that are random, uneasy one's own department or unit respectively pacify its position.
Summary of the invention
The invention provides one and treat hypertensive point-application prescription and using method thereof, point-application prescription of the present invention, formula is unique, and medicine letter power is special, and effect is distinguished.There is the vital essence of taking good care of Liver and kidney, conducting blood to flow downwards, stabilize wind sun, the effect of Heibei provincial opera vim and vigour.
Treatment of the present invention hypertensive point-application prescription is prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 20 ~ 40 parts, Magnetitum 20 ~ 40 parts, Radix Achyranthis Bidentatae 20 ~ 40 parts, the Cortex Eucommiae 20 ~ 40 parts, 20 ~ 40 parts, Rhizoma Gastrodiae, Dens Draconis 20 ~ 40 parts, 1 ~ 5 part, Cinnabaris.
According to above-mentioned global schema, in conjunction with clinical practice application, we sum up several preferred version:
Scheme 1, described point-application prescription is prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 30 parts, Magnetitum 30 parts, Radix Achyranthis Bidentatae 30 parts, the Cortex Eucommiae 30 parts, 30 parts, Rhizoma Gastrodiae, Dens Draconis 30 parts, 3 parts, Cinnabaris.
Scheme 2, described point-application prescription is prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 23 parts, Magnetitum 21 parts, Radix Achyranthis Bidentatae 26 parts, the Cortex Eucommiae 25 parts, 28 parts, Rhizoma Gastrodiae, Dens Draconis 36 parts, 2 parts, Cinnabaris.
Scheme 3, described point-application prescription is prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 33 parts, Magnetitum 35 parts, Radix Achyranthis Bidentatae 32 parts, the Cortex Eucommiae 37 parts, 39 parts, Rhizoma Gastrodiae, Dens Draconis 34 parts, 4 parts, Cinnabaris.
Scheme 4, described point-application prescription is prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 29 parts, Magnetitum 32 parts, Radix Achyranthis Bidentatae 34 parts, the Cortex Eucommiae 28 parts, 30 parts, Rhizoma Gastrodiae, Dens Draconis 39 parts, 5 parts, Cinnabaris.
Scheme 5, described point-application prescription is prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 26 parts, Magnetitum 24 parts, Radix Achyranthis Bidentatae 27 parts, the Cortex Eucommiae 21 parts, 26 parts, Rhizoma Gastrodiae, Dens Draconis 29 parts, 3 parts, Cinnabaris.
Scheme 6, described point-application prescription is prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 34 parts, Magnetitum 36 parts, Radix Achyranthis Bidentatae 33 parts, the Cortex Eucommiae 38 parts, 35 parts, Rhizoma Gastrodiae, Dens Draconis 33 parts, 3 parts, Cinnabaris.
Scheme 7, described point-application prescription is prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 28 parts, Magnetitum 25 parts, Radix Achyranthis Bidentatae 29 parts, the Cortex Eucommiae 33 parts, 39 parts, Rhizoma Gastrodiae, Dens Draconis 38 parts, 4 parts, Cinnabaris.
Scheme 8, described point-application prescription is prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 36 parts, Magnetitum 34 parts, Radix Achyranthis Bidentatae 28 parts, the Cortex Eucommiae 26 parts, 29 parts, Rhizoma Gastrodiae, Dens Draconis 35 parts, 3 parts, Cinnabaris.
Fructus Evodiae is mainly used in conducting blood to flow downwards, and its hypotensive effect mainly makes peripheral blood vessel expand and reduce peripheral vascular resistance, and relevant with histamine release.Therefore, it has obvious hypotensive effect, and the persistent period is long, generally reaches more than 3 hours.Cinnabaris simply merit is calm in YANG hyperactivity suppressing, and modern study more has nervous system regulation effect, with the power of its subduing the hyperactivity of YANG of the compatible enhancing of Magnetitum.Radix Achyranthis Bidentatae, the Cortex Eucommiae two taste take good care of Liver and kidney, and antihypertensive effect is definite, is clinical commonly used drug.Radix Achyranthis Bidentatae invigorating the liver and kidney, diuretic, conducting blood to flow downwards.The Cortex Eucommiae, containing natural active matters such as eucommia bark flavone (Quercetin), chlorogenic acid, Geniposidic acid, aucubins, protects the liver tune fat, regulates cardiovascular function, has two-way regulating function to blood pressure.
The using method of the hypertensive point-application prescription for the treatment of of the present invention chooses vola Yongquan acupoint to stick, and changes subsides every day, and continuing two weeks is a course for the treatment of.
Beneficial effect of the present invention is as follows: point-application prescription formula of the present invention is unique, and medicine letter power is special, and effect is distinguished.There is the vital essence of taking good care of Liver and kidney, conducting blood to flow downwards, stabilize wind sun, the effect of Heibei provincial opera vim and vigour.Patient only need stick on the Yongquan acupoint in vola by the course for the treatment of, and Therapeutic Method is easy, and safe devoid of risk, effect is distinguished.
Detailed description of the invention
In order to make technology contents of the present invention more easily be understood, detailed elaboration is done to technical scheme of the present invention below.
Treatment of the present invention hypertensive point-application prescription is prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 20 ~ 40g, Magnetitum 20 ~ 40g, Radix Achyranthis Bidentatae 20 ~ 40g, the Cortex Eucommiae 20 ~ 40g, Rhizoma Gastrodiae 20 ~ 40g, Dens Draconis 20 ~ 40g, Cinnabaris 1 ~ 5g.
According to above-mentioned global schema, in conjunction with clinical practice application, we sum up following specific embodiments:
Embodiment 1
Treat hypertensive point-application prescription to be prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 30g, Magnetitum 30g, Radix Achyranthis Bidentatae 30g, Cortex Eucommiae 30g, Rhizoma Gastrodiae 30g, Dens Draconis 30g, Cinnabaris 3g.
Embodiment 2
Treat hypertensive point-application prescription to be prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 23g, Magnetitum 21g, Radix Achyranthis Bidentatae 26g, Cortex Eucommiae 25g, Rhizoma Gastrodiae 28g, Dens Draconis 36g, Cinnabaris 2g.
Embodiment 3
Treat hypertensive point-application prescription to be prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 33g, Magnetitum 35g, Radix Achyranthis Bidentatae 32g, Cortex Eucommiae 37g, Rhizoma Gastrodiae 39g, Dens Draconis 34g, Cinnabaris 4g.
Embodiment 4
Treat hypertensive point-application prescription to be prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 29g, Magnetitum 32g, Radix Achyranthis Bidentatae 34g, Cortex Eucommiae 28g, Rhizoma Gastrodiae 30g, Dens Draconis 39g, Cinnabaris 5g.
Embodiment 5
Treat hypertensive point-application prescription to be prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 26g, Magnetitum 24g, Radix Achyranthis Bidentatae 27g, Cortex Eucommiae 21g, Rhizoma Gastrodiae 26g, Dens Draconis 29g, Cinnabaris 3g.
Embodiment 6
Treat hypertensive point-application prescription to be prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 34g, Magnetitum 36g, Radix Achyranthis Bidentatae 33g, Cortex Eucommiae 38g, Rhizoma Gastrodiae 35g, Dens Draconis 33g, Cinnabaris 3g.
Embodiment 7
Treat hypertensive point-application prescription to be prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 28g, Magnetitum 25g, Radix Achyranthis Bidentatae 29g, Cortex Eucommiae 33g, Rhizoma Gastrodiae 39g, Dens Draconis 38g, Cinnabaris 4g.
Embodiment 8
Treat hypertensive point-application prescription to be prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 36g, Magnetitum 34g, Radix Achyranthis Bidentatae 28g, Cortex Eucommiae 26g, Rhizoma Gastrodiae 29g, Dens Draconis 35g, Cinnabaris 3g.
The using method of the hypertensive point-application prescription for the treatment of of the present invention chooses vola Yongquan acupoint to stick, and changes subsides every day, and continuing two weeks is a course for the treatment of.
The foregoing is only embodiments of the invention; not thereby the scope of the claims of the present invention is limited; every utilize description of the present invention to do equivalent structure or the conversion of equivalent flow process, or be directly or indirectly used in other relevant technical fields, include in scope of patent protection of the present invention.
The treatment hypertensive point-application prescription thing adopting above-described embodiment to provide carries out clinical experiment, achieves significant effect, and without bad toxicity.
Case 1: Lee, man, 69 years old, people from Fuqing.In August, 2013 seeks medical advice because of symptoms such as dizziness, headaches, records its systolic pressure 175mmHg, diastolic pressure 98mmHg, be diagnosed as hypertension, often take the medicine such as indapamide tablets, captopril afterwards, make systolic pressure maintain 140mmHg ~ 160mmHg, diastolic pressure maintains 80mmHg ~ 100mmHg.Recently because of fatigue there is headache, the symptom such as dizziness increases the weight of, insomnia, record its systolic pressure 160mmHg, diastolic pressure 95mmHg.Stick in vola Yongquan acupoint by point-application prescription of the present invention, every day is changed once, continues two weeks.Further consultation after two weeks, transference cure, records its systolic pressure 130mmHg, diastolic pressure 80mmHg.Advise it that point-application prescription of the present invention is affixed on vola Yongquan acupoint and SHENQUE acupoint sentences maintenance curative effect, a check in a month blood pressure, in half a year, blood pressure maintains normal level always.
Case 2: high certain, man, 75 years old, permanently happy people.In June, 2012 seeks medical advice because of symptoms such as dizziness, cardiopalmus, insomnias, recording its systolic pressure is 180mmHg, diastolic pressure is 100mmHg, be diagnosed as hypertension, often take indapamide tablets afterwards, each 2.5mg(a slice), once a day, make systolic pressure maintain 120mmHg ~ 160mmHg, diastolic pressure maintains 90mmHg ~ 110mmHg.Recently because headache, dizziness, cardiopalmus, insomnia, the symptoms such as conjunctival congestion, two cheekbones are rubescent, bitter taste in the mouth and dry throat of being envious appear in fatigue, recording its systolic pressure is 185mmHg, and diastolic pressure is 110mmHg, and electrocardio illustrates sinus rhythm, and heart rate 76 beats/min, electrocardiogram is roughly normal.Stick in vola Yongquan acupoint by point-application prescription of the present invention, every day is changed once, continues two weeks.Further consultation after two weeks, symptom is obviously alleviated, and recording its systolic pressure is 128mmHg, and diastolic pressure is 93mmHg, and continue to paste medicine two weeks rear symptoms and disappear completely, recording its systolic pressure is 124mmHg, and diastolic pressure is 80mmHg.Advise it to stick in vola Yongquan acupoint by point-application prescription of the present invention, every day is changed once, then continues fortnight, and check blood pressure maintains normal level always.
Case 3: Liu, female, 80 years old, people from Foochow.In August, 2014 seeks medical advice because having a headache, and record its systolic pressure 150mmHg, diastolic pressure 90mmHg, is diagnosed as hypertension.Stick in vola Yongquan acupoint by point-application prescription of the present invention, every day is changed once, continues two weeks, records its systolic pressure 120mmHg, diastolic pressure 70mmHg.Advise its less salt low fat diet, keep happy, and stick in vola Yongquan acupoint by point-application prescription of the present invention, every day is changed once, and to maintain curative effect, fortnight checks a blood pressure, and blood pressure maintains normal range always so far.
Claims (10)
1. the hypertensive point-application prescription for the treatment of, it is characterized in that, described point-application prescription is prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 20 ~ 40 parts, Magnetitum 20 ~ 40 parts, Radix Achyranthis Bidentatae 20 ~ 40 parts, the Cortex Eucommiae 20 ~ 40 parts, 20 ~ 40 parts, Rhizoma Gastrodiae, Dens Draconis 20 ~ 40 parts, 1 ~ 5 part, Cinnabaris.
2. the hypertensive point-application prescription for the treatment of according to claim 1, is characterized in that, described point-application prescription is prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 30 parts, Magnetitum 30 parts, Radix Achyranthis Bidentatae 30 parts, the Cortex Eucommiae 30 parts, 30 parts, Rhizoma Gastrodiae, Dens Draconis 30 parts, 3 parts, Cinnabaris.
3. the hypertensive point-application prescription for the treatment of according to claim 1, is characterized in that, described point-application prescription is prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 23 parts, Magnetitum 21 parts, Radix Achyranthis Bidentatae 26 parts, the Cortex Eucommiae 25 parts, 28 parts, Rhizoma Gastrodiae, Dens Draconis 36 parts, 2 parts, Cinnabaris.
4. the hypertensive point-application prescription for the treatment of according to claim 1, is characterized in that, described point-application prescription is prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 33 parts, Magnetitum 35 parts, Radix Achyranthis Bidentatae 32 parts, the Cortex Eucommiae 37 parts, 39 parts, Rhizoma Gastrodiae, Dens Draconis 34 parts, 4 parts, Cinnabaris.
5. the hypertensive point-application prescription for the treatment of according to claim 1, is characterized in that, described point-application prescription is prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 29 parts, Magnetitum 32 parts, Radix Achyranthis Bidentatae 34 parts, the Cortex Eucommiae 28 parts, 30 parts, Rhizoma Gastrodiae, Dens Draconis 39 parts, 5 parts, Cinnabaris.
6. the hypertensive point-application prescription for the treatment of according to claim 1, is characterized in that, described point-application prescription is prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 26 parts, Magnetitum 24 parts, Radix Achyranthis Bidentatae 27 parts, the Cortex Eucommiae 21 parts, 26 parts, Rhizoma Gastrodiae, Dens Draconis 29 parts, 3 parts, Cinnabaris.
7. the hypertensive point-application prescription for the treatment of according to claim 1, is characterized in that, described point-application prescription is prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 34 parts, Magnetitum 36 parts, Radix Achyranthis Bidentatae 33 parts, the Cortex Eucommiae 38 parts, 35 parts, Rhizoma Gastrodiae, Dens Draconis 33 parts, 3 parts, Cinnabaris.
8. the hypertensive point-application prescription for the treatment of according to claim 1, is characterized in that, described point-application prescription is prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 28 parts, Magnetitum 25 parts, Radix Achyranthis Bidentatae 29 parts, the Cortex Eucommiae 33 parts, 39 parts, Rhizoma Gastrodiae, Dens Draconis 38 parts, 4 parts, Cinnabaris.
9. the hypertensive point-application prescription for the treatment of according to claim 1, is characterized in that, described point-application prescription is prepared from by the raw material of Chinese medicine of following parts by weight: Fructus Evodiae 36 parts, Magnetitum 34 parts, Radix Achyranthis Bidentatae 28 parts, the Cortex Eucommiae 26 parts, 29 parts, Rhizoma Gastrodiae, Dens Draconis 35 parts, 3 parts, Cinnabaris.
10. the using method of the hypertensive point-application prescription of the treatment according to any one of claim 1 ~ 9, is characterized in that, this prescription external acupoint selection, chooses vola Yongquan acupoint and stick.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510533053.4A CN105055922B (en) | 2015-08-27 | 2015-08-27 | A kind of point-application prescription that treating hypertension and its application method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510533053.4A CN105055922B (en) | 2015-08-27 | 2015-08-27 | A kind of point-application prescription that treating hypertension and its application method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105055922A true CN105055922A (en) | 2015-11-18 |
| CN105055922B CN105055922B (en) | 2018-10-16 |
Family
ID=54485598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510533053.4A Active CN105055922B (en) | 2015-08-27 | 2015-08-27 | A kind of point-application prescription that treating hypertension and its application method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105055922B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107158253A (en) * | 2016-03-01 | 2017-09-15 | 南京中易抗衰老技术开发有限公司 | A kind of Chinese medicinal ointment of bidirectional modulation blood pressure and preparation method thereof |
| CN116098957A (en) * | 2023-01-06 | 2023-05-12 | 中国中医科学院广安门医院 | Acupoint application formula for reducing blood pressure |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102755538A (en) * | 2012-07-17 | 2012-10-31 | 吴焕琳 | Lavipeditum traditional Chinese medicine composition for lowering blood pressure and preparation method thereof |
| CN103110723A (en) * | 2013-03-06 | 2013-05-22 | 商南县本草国医养生有限公司 | Externally-applied TCM (traditional Chinese medicine) patch for treating hypertension |
-
2015
- 2015-08-27 CN CN201510533053.4A patent/CN105055922B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102755538A (en) * | 2012-07-17 | 2012-10-31 | 吴焕琳 | Lavipeditum traditional Chinese medicine composition for lowering blood pressure and preparation method thereof |
| CN103110723A (en) * | 2013-03-06 | 2013-05-22 | 商南县本草国医养生有限公司 | Externally-applied TCM (traditional Chinese medicine) patch for treating hypertension |
Non-Patent Citations (3)
| Title |
|---|
| 方奇: "复方吴茱萸散敷涌泉穴治疗高血压106例", 《中医外治杂志》 * |
| 王夏叶: "强力天麻杜仲胶囊治疗高血压病肝阳上亢症疗效观察", 《黑龙江中医药》 * |
| 钱松林等: "耳穴贴压加穴位贴敷降压散治疗高血压病215例小结", 《新疆中医药》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107158253A (en) * | 2016-03-01 | 2017-09-15 | 南京中易抗衰老技术开发有限公司 | A kind of Chinese medicinal ointment of bidirectional modulation blood pressure and preparation method thereof |
| CN116098957A (en) * | 2023-01-06 | 2023-05-12 | 中国中医科学院广安门医院 | Acupoint application formula for reducing blood pressure |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105055922B (en) | 2018-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108210867A (en) | A kind of palm moxibustion liquid for treating pain and preparation method thereof | |
| CN102526276B (en) | Anti-hypertension medicinal composition and preparation method for same | |
| CN105055922A (en) | Acupuncture point application composition for treating hypertension and using method thereof | |
| CN104013702B (en) | One treats hypertensive fumigation and wash method foot bath Chinese medicine | |
| CN104083438A (en) | Balsam pear-containing traditional Chinese medicinal preparation for alleviating hypertension, and preparation method thereof | |
| CN105055478A (en) | Traditional Chinese medicinal health composition and traditional Chinese medicine health pillow | |
| CN103041119B (en) | One treats cardiopathic Chinese medicine | |
| CN101361797B (en) | Traditional Chinese medicine pressure-reduction insoles | |
| CN104000903B (en) | A kind of smoked lavipeditum Chinese medicine of washing for the treatment of diabetic peripheral neuritis | |
| CN102526452A (en) | Traditional Chinese medicine decoction for treating sick sinus syndrome | |
| CN102961561B (en) | Chinese medicinal composition for treating coronary heart disease | |
| CN106389098B (en) | A kind of instrument for treating pain in the back | |
| CN103798472A (en) | Healthcare tea and healthcare life-maintaining preparation | |
| CN103656170A (en) | Tea for treating hypotension | |
| CN108355066A (en) | A kind of apoplexy Physiotherapeutic medicated pillow | |
| CN104223062B (en) | Root bark of Chinese wolf-berry health care oral liquid of a kind of reducing pressure and sugar and preparation method thereof | |
| CN102068629A (en) | Medicinal hat for assisting in treating primary hypertension | |
| CN102266528B (en) | Medicament for treating hypertension | |
| CN107260978A (en) | A kind of Chinese medicine composition and its production and use | |
| CN102670718A (en) | Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and preparation method of same | |
| CN100512865C (en) | External application medicine for treating hypertension | |
| CN106729538A (en) | A kind of foot-bathing health-care agent and preparation method thereof | |
| CN101698048A (en) | Traditional Chinese medicine ointment for treating high blood pressure and preparation method thereof | |
| CN102641409B (en) | Traditional Chinese medicine for treating onychomycosis | |
| CN102949466A (en) | Foot bathing liquid for yang promotion and solid doff |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |